Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Apr 14;10:94.
doi: 10.1186/1471-2334-10-94.

Dosage Effect on Uropathogenic Escherichia Coli Anti-Adhesion Activity in Urine Following Consumption of Cranberry Powder Standardized for Proanthocyanidin Content: A Multicentric Randomized Double Blind Study

Affiliations
Free PMC article
Randomized Controlled Trial

Dosage Effect on Uropathogenic Escherichia Coli Anti-Adhesion Activity in Urine Following Consumption of Cranberry Powder Standardized for Proanthocyanidin Content: A Multicentric Randomized Double Blind Study

Amy B Howell et al. BMC Infect Dis. .
Free PMC article

Abstract

Background: Ingestion of cranberry (Vaccinium macrocarpon Ait.) has traditionally been utilized for prevention of urinary tract infections. The proanthocyanidins (PACs) in cranberry, in particular the A-type linkages have been implicated as important inhibitors of primarily P-fimbriated E. coli adhesion to uroepithelial cells. Additional experiments were required to investigate the persistence in urine samples over a broader time period, to determine the most effective dose per day and to determine if the urinary anti-adhesion effect following cranberry is detected within volunteers of different origins.

Methods: Two separate bioassays (a mannose-resistant hemagglutination assay and an original new human T24 epithelial cell-line assay) have assessed the ex-vivo urinary bacterial anti-adhesion activity on urines samples collected from 32 volunteers from Japan, Hungary, Spain and France in a randomized, double-blind versus placebo study. An in vivo Caenorhabditis elegans model was used to evaluate the influence of cranberry regimen on the virulence of E. coli strain.

Results: The results indicated a significant bacterial anti-adhesion activity in urine samples collected from volunteers that consumed cranberry powder compared to placebo (p < 0.001). This inhibition was clearly dose-dependent, prolonged (until 24 h with 72 mg of PAC) and increasing with the amount of PAC equivalents consumed in each cranberry powder regimen. An in vivo Caenorhabditis elegans model showed that cranberry acted against bacterial virulence: E. coli strain presented a reduced ability to kill worms after a growth in urines samples of patients who took cranberry capsules. This effect is particularly important with the regimen of 72 mg of PAC.

Conclusions: Administration of PAC-standardized cranberry powder at dosages containing 72 mg of PAC per day may offer some protection against bacterial adhesion and virulence in the urinary tract. This effect may offer a nyctohemeral protection.

Figures

Figure 1
Figure 1
Fluorescence microscopy of E. coli gfp + strain cultured in urines of volunteers collected after cranberry powder consumption and loaded on T24 epithelial cells. A. E. coli cultured in urines collected after placebo consumption; B. E. coli cultured in urines collected 6 h after consumption of cranberry powder containing 18 mg proanthocyanidins (PAC); C. E. coli cultured in urines collected 6 h after consumption of cranberry powder containing 36 mg PAC; D. E. coli cultured in urines collected 6 h after consumption of cranberry powder containing 72 mg PAC.

Similar articles

See all similar articles

Cited by 53 articles

See all "Cited by" articles

References

    1. Jepson RG, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database of Syst Rev. 2008;1:CD001321. - PubMed
    1. Sobota AE. Inhibition of bacterial adherence by cranberry juice: potential use for the treatment of urinary tract infections. J Urol. 1984;131:1013–1016. - PubMed
    1. Zafriri D, Ofek I, Adar R, Pocino M, Sharon N. Inhibitory activity of cranberry juice on adherence of type I and type P fimbriated Escherichia coli to eucaryotic cells. Antimicrob Agents Chemother. 1989;33:92–98. - PMC - PubMed
    1. Ofek I, Goldhar J, Zafriri D, Lis H, Adar R, Sharon N. Anti-Escherichia coli adhesin activity of cranberry and blueberry juices. N Engl J Med. 1991;324:1599. - PubMed
    1. Beachey EH. Bacterial adherence: Adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface. J Infect Dis. 1981;143:325–345. - PubMed

Publication types

LinkOut - more resources

Feedback